THURSDAY | APRIL 30, 2020
|
|
On April 27, we sent you a toolkit explaining morbidity risk mitigation flowchart for IPM and ASIPP risk stratification of patients presenting for pain procedures. This toolkit is for Phase I only.
Since releasing it, we have received multiple comments. There have been a few comments and requests for changes. In response, we have taken another look at it and made the appropriate changes. Please look over each document.
As we mentioned before, ASIPP Task Force Committee with Shalini, Sudhir, Amol, Chris, and Kartic worked extremely hard in arriving at this document, spending countless hours in the preparation of them.
Since then, we have also received comments from member of various states explaining that they can either do the testing on all patients or follow the association guidelines, so this will be a great opportunity for you to use them in your state. If the State Department of Health guidelines are too harsh, we can send them an explanatory letter.
Please look over these documents listed below. Remove all the old documents and replace with these latest revisions.
|
|
COMPREHENSIVE PHYSICIAN AND PRACTICE
REHABILITATION TRAINING (CPPR)
Tuesday, May 5, 2020 | 5:00pm – 7:00pm CDT
AGENDA
|
|
|
|
CPPR Training Overview –
Laxmaiah Manchikanti, MD
|
|
|
|
Summary of Financial Reckoning and Rehabilitation –
Amol Soin, MD
|
|
|
|
Reaching Out Through Social Media in the Corona Era –
Devi Nampiaparampil, MD
|
|
|
|
Quality and Value: Hallmarks of ASIPP –
Sunny Jha, MD
|
|
|
|
Time Management –
Shelly Baer, LCSW, SAP
|
|
|
|
Congressional Overview -
Senator Bill Cassidy
|
|
|
|
Open Forum Discussion –
Laxmaiah Manchikanti, MD
,
Amol Soin, MD
, and
Devi Nampiaparampil, MD
;
Harold Cordner, MD
;
Shalini Shah, MD
;
Sunny Jha, MD
;
Shelly Baer, LCSW, SAP
|
|
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Institute for Medical Studies and the American Society of Interventional Pain Physicians (ASIPP®). The Institute for Medical Studies is accredited by the ACCME to provide continuing medical education for physicians.
CATEGORY I CREDIT
The Institute for Medical Studies designates the Interventional Techniques Comprehensive Review Course online activity for a maximum of 2
AMA PRA Category 1 Credits™
Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
|
Dr. Devi Nampiaparampil Pens Book
|
Hospitals and healthcare workers struggle to keep up with the demand as the new coronavirus (COVID-19) spreads across the U.S. and throughout the world.
Hundreds of millions of people are social distancing, quarantining, and sheltering in place to slow down the spread of the virus. The stock market is plunging and the global economy is heading into a recession because of the virus and because of the measures we are enforcing to stop it. Schools are closed. Restaurants, bars, and gyms are closed in many areas of the country. Major sports events, concerts and shows have been cancelled. Perhaps our greatest asset in this fight against the new coronavirus-- healthcare workers-- are becoming infected on the front lines. In the midst of this crisis, Doctor Devi explains what you need to know in a concise and easy-to-understand Question and Answer format.
Dr. Devi Nampiaparampil, a Harvard-trained doctor and a professor at NYU School of Medicine, breaks down the issues in this clear and compassionate handbook. What makes this virus so dangerous? How can I protect myself and my family? How did this happen?
For the latest guidelines, please always check:
|
|
Call for COVID-19 Submissions:
PAIN PHYSICIAN
PAIN MEDICINE CASE REPORTS
|
|
Manuscripts related to COVID-19 and interventional pain management are now being solicited for a special issue of
Pain Physician
.
We will publish articles on prevention, diagnosis, treatment, including epidemiology, pathophysiology, pharmacology. Plus articles risks of interventional techniques, risks of anesthesia, precautions, and preventive measures.
Pain Physician
, the official journal of the American Society of Interventional Pain Physicians is and open access journal listed in Embase, SCOPUS, PubMed, and Medline.
Pain Medicine Case Reports
journal is also requesting submissions. PMCR is the sister journal to
Pain Physician
that focuses solely on Case Reports and Case Series. Articles submitted to PMCR will need to be Case Reports or Case Studies only that relate to COVID-19.
Pain Medicine Case Reports
is an open access journal, available online with free full manuscripts. It is listed in SCOPUS, Embase, ScienceDirect, Evolve, and Clinical Key.
Articles for both journals will go through rapid review and rapid publication.
|
|
Pain Physician March/April
2020 Articles Available Online Now
|
|
The March/April issue of
Pain Physician
features
Position Statement
Laxmaiah Manchikanti, MD, Christopher J. Centeno, MD, Sairam Atluri, MD, Sheri L. Albers, DO, Shane Shapiro, MD, Gerard A. Malanga, MD, Alaa Abd-Elsayed, MD, MPH, Mairin Jerome, MD, Joshua A. Hirsch, MD, Alan D. Kaye, MD, PhD, Steve M. Aydin, DO, Douglas Beall, MD, Don Buford, MD, Joanne Borg-Stein, MD, Ricardo Buenaventura, MD, Joseph A. Cabaret, MD, Aaron K. Calodney, MD, Kenneth D. Candido, MD, Cameron Cartier, MD, Richard Latchaw, MD, Sudhir Diwan, MD, Ehren Dodson, PhD, Zachary Fausel, MD, Michael Fredericson, MD, Christopher G. Gharibo, MD, Myank Gupta, MD, Adam M. Kaye, PharmD, FASCP, FCPhA, Nebojsa Nick Knezevic, MD, PhD, Radomir Kosanovic, MD, Matthew Lucas, DO, Maanasa V. Manchikanti , R. Amadeus Mason, MD, Kenneth Mautner, MD, Samuel Murala, MD, Annu Navani, MD, Vidyasagar Pampati, MSc, Sarah Pastoriza, DO, Ramarao Pasupuleti, MD, Cyril Philip, MD, Mahendra Sanapati, MD, Theodore Sand, PhD, Rinoo Shah, MD, Amol Soin, MD, Ian Stemper, MS, Bradley W. Wargo, DO, and Philippe Hernigou, MD
Health Policy Review
Laxmaiah Manchikanti, MD, Mahendra R. Sanapati, MD, Amol Soin, MD, Maanasa V. Manchikanti, BS, Vidyasagar Pampati, MSc, Vanila Singh, MD, and Joshua A. Hirsch, MD
Systematic Reviews
Jianwei Wang, MS, Zifeng Xu, MD, Zhou Feng, MS, Rui Ma, BS, and Xiaoyu Zhang, MS
Felipe Araya-Quintanilla, MSc, Hector Gutierrez-Espinoza, PhD, Maria Jesus Munoz-Yanez, MSc, Ursula Sanchez-Montoya, MSc, and Juan Lopez-Jeldes, MSc
|
|
Gilead Sciences Says Potential Coronavirus Drug Shows Promise in Study
|
|
POSITIVE DATA IS emerging from the study of a possible COVID-19 treatment, according to biotech company Gilead Sciences.
A trial of the antiviral drug remdesivir by the National Institute of Allergy and Infectious Diseases "has met its primary endpoint," the company said on Wednesday.
More information about the development will be provided by the institute in an upcoming briefing, according to the announcement.
|
|
Pain Management
Workgroup to Hold Evidence Review Advisory Meeting
|
|
Please find the
letter
addressed to American Society of Interventional Pain Physicians, along with other pain organizations from the Pain Management Workgroup Evidence Review advisory meeting with important updates.
They are planning an evidence review advisory meeting for LCD policies on facet joint injections and medial nerve branch procedures. The meeting, which will be a combined meeting with all Medicare Administrative Contractors (MACs), is currently planned for May 28th in Nashville and as a teleconference. A link to the meeting and registration information will be posted to each MAC’s website and the CMS Landing Page within the next 2‐3 weeks. ASIPP will be watching for this posting and will notify you so that you may register to attend.
Some of the ASIPP members are already serving on this committee; however, it is crucial that each state contact their own carriers and try to represent them. We need as many people as you can participate.
It is very crucial that you participate and understand. If you register you should be able to ask questions and give opinions, etc.
Please block your time for May 28
th
from 1:00 to 3:00 pm CST.
|
|
April 24, Webinar archive
April 7, Webinar archive
April 3 Webinar archive
March 27 Webinar archive
|
|
Stakeholder Views on Pain Management Requested
|
|
June 16 Deadline for Perspectives and Experiences
The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment concerning perspectives on and experiences with pain and pain management, including but not limited to the benefits and harms of opioid use, from patients with acute or chronic pain, patients' family members and/or caregivers, and health care providers who care for patients with pain or conditions that can complicate pain management (
e.g.,
opioid use disorder or overdose)—hereafter called “stakeholders.” CDC will use these comments to inform its understanding of stakeholders' values and preferences related to pain and pain management options.
Written comments must be received on or before June 16, 2020.
Submit written comments, identified by Docket No. CDC-2020-0029 by any of the following methods:
·
Mail:
Shannon Lee, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop S106-9, Atlanta, Georgia 30329.
Instructions:
All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to
http://regulations.gov
,
including any personal information provided. For access to the docket to read background documents or comments received, go to
http://www.regulations.gov
.
|
|
Opinion: Will Life and Medicine Go Back to Normal After COVID-19?
|
|
I have not written a
blog post
since October 2019. For the last 6 months, life had become too busy, and I had no time to write anything of quality. If I did not have the time to say something of value, it was good to remain quiet.
The world of October 2019 no longer exists. Our lives have been transformed in ways that we could not possibly have imagined. Many already thought that the world was an irrational, unkind, and dysfunctional place in October of last year. Now, they refer to that period -- a mere 6 months ago -- as a time of "normality."
Normality? Is that the right word? Many people think that the word that refers to a state of being normal is "normalcy." But "normalcy" did not assume its current meaning until Warren Harding used it (incorrectly) in a speech during his 1920 presidential election campaign. His slogan was "Return to Normalcy," a plea to return to the way things were before World War I.
|
|
CMS Ends Advance Payments for Physicians, Other Part B Providers
|
|
The federal agency is also reevaluating the amounts paid under the Accelerated Payment Program, a similar advance payment initiative for hospitals during emergencies.
April 27, 2020 - CMS recently
announced
that it has suspended the Advance Payment Program for physicians, non-physician practitioners, and other qualifying Medicare Part B suppliers during the COVID-19 pandemic.
According to the April 26 announcement, the federal agency is also reevaluating the reimbursement amounts paid under its Accelerated Payment Program, a similar advance payment initiative that supports fee-for-service Medicare providers when there is a disruption in claims submission and/or processing.
|
|
We are currently looking for reviewers for Pain Physician
We would like to take this opportunity to ask if you would be interested in a position as a Reviewer on the Editorial Board for Pain Physician or if you have a recommendation for someone who might be interested.
Editorial Board responsibilities are as follows:
- Review a minimum of 6 manuscripts per year.
- Failure to review 2 manuscripts consecutively or 60% of the manuscripts sent will disqualify one from Editorial Board Membership.
|
|
For more information or to submit your letter of interest, please e-mail:
|
|
ASIPP
®
Partners with Fedora Billing And Revenue Cycle
Management Company
|
|
After long discussions, in addition to our NorCal liability program for
ASIPP
®
members, now we are able to offer unique benefits for revenue cycle management with billing, etc.
Fedora
is a company known to many of our board members and others.
ASIPP
®
has reached an agreement with Fedora to provide exclusive discounts on billing or revenue cycle management that will decrease practice costs and promote growth, or at least stop deterioration. It is not just a billing company; they streamline the billing and receivable process and constantly update payor regulations keeping your practice up to on date on a daily basis.
Some of the
ASIPP
®
Billing Program highlights are below:
Up to 50% savings for
ASIPP
®
members for their billing or revenue cycle management for their offices and surgery centers:
- Expertise in interventional pain management billing for all types of services
- 99% Clearing House Rate
- 95% First-Time Claim Passage
- 23.4 Average Days in A/R
- Eligibility and Benefits Verification
- Pre-Certification/Prior Authorization
- Denials and A/R Management
|
|
Join The Group Purchasing Organization Today
|
|
ASIPP
®
has formed a partnership with
Henry Schein
and
PedsPal
, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today. While the cost of contrast media has skyrocketed due to the single dose vial issue, because we have partnered with Henry Schein, this could enable you to purchase Omnipaque 240mg/50mL for slightly above $4.50.
It will be easy for
ASIPP
®
members in good standing to enroll today and begin to realize the savings this partnership can bring. Members can join or see sample prices by going to
http://pedspal.org/asipp/default.html
Click on “view our discounted supplier prices” (Username:ASIPPmember and Password: Save) or click on the words "join for free now" and begin saving today!
|
|
COVID-19 Continues to Strike Men Harder Than Women
|
|
April 29, 2020 (HealthDay News) -- New research adds to a growing body of evidence that suggests men are far more vulnerable to severe COVID-19 than women are.
Although both genders fall ill in the same numbers, men are 2.5 times more likely to get severe disease and die, the study from China showed.
The finding comes as scientists in New York and California are starting to test a novel hypothesis that sex hormones might play a part in disease severity.
|
|
The Food and Drug Administration's Role in Facilitating Testing for COVID-19
|
|
When the Secretary of the Department of Health and Human Services determines that there is a public health emergency and declares that circumstances exist justifying an Emergency Use Authorization (EUA), the Food and Drug Administration (FDA) can issue an EUA under section 564 of the Federal Food, Drug, and Cosmetic Act. An EUA allows for the use of certain unapproved medical products, or unapproved uses of certain approved medical products, to diagnose, treat, or prevent serious or life-threatening diseases when there are no adequate, approved, and available alternatives.
FDA issued the first COVID-19 EUA for a diagnostic test to the Centers for Disease Control and Prevention and issued subsequent EUAs to other laboratories. This work will examine FDA's EUA processes and any challenges it may have faced regarding EUAs for COVID-19 diagnostic tests and serological tests for antibodies developed in response to the viral infection.
|
|
We are currently looking for reviewers for Pain MedicineCase Reports
We would like to take this opportunity to ask if you would be interested in a position as a Reviewer on the Editorial Board for Pain Medicine Case Reports or if you have a recommendation for someone who might be interested.
Editorial Board responsibilities are as follows:
- Review a minimum of 6 manuscripts per year.
- Failure to review 2 manuscripts consecutively or 60% of the manuscripts sent will disqualify one from Editorial Board Membership.
|
|
For more information or to submit your letter of interest, please e-mail:
|
|
Essentials of Regenerative Medicine in Interventional
Pain Management
|
|
|
|
Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine in managing chronic pain. Regenerative medicine is an integral part of interventional pain management within the definitions of interventional pain management and interventional techniques.
Each chapter contains an introduction of the subject, historical context,pathophysiology, applicability of regenerative medicine with its evidence base, indications, anatomy, technical aspects, complications, and precautions for each topic when available and applicable. This comprehensive book consists of 35 chapters, more than 350 figures, and 50 tables.
|
|
Essentials of Regenerative Medicine in Interventional Pain Management
|
ORDER
|
|
|
Control Your Waiting Room TV
Customized waiting room TV exclusively for
ASIPP
®
members. Create your own ad-free television broadcasts using our videos, custom informational slides and your own YouTube videos. Even add local weather reports, news and live messages.
|
|
|
|
|
|
GSIPP 16th Annual Pain Summit
|
|
The Ritz-Carlton Reynolds Plantation
Lake Oconee
|
|
|
|
|
|
|
FSIPP/FSPM
Annual Meeting
|
|
|
|
|
|
|
|
2020 12th Annual Scientific
Meeting
|
|
|
|
|
|
|
|
|
|
